Home › Funds › Encore Global Management, LP › MRNA

Encore Global Management, LP position in MRNA

MODERNA INC · Health Care

Encore Global Management, LP reported holding 1,000 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$193K, representing 0.21% of its reported portfolio and ranking #45 among its reported holdings. Encore Global Management, LP has disclosed MRNA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)1.00K sh
Reported value held$192.57K
Portfolio Weight0.21%
First reportedQ1 2026
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Encore Global Management, LP's MRNA position evolved

Encore Global Management, LP first disclosed a stake in MRNA in Q1 2026 at 1,000 shares (US$51K). The position peaked in Q3 2026 at 1,000 shares, worth US$193K. Across 3 filings, Encore Global Management, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,000 shares valued at US$193K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.00K $50.80K New
Q2 2026 1.00K $70.03K Hold
Q3 2026 1.00K $192.57K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 37 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Encore Global Management, LP held MRNA?

Encore Global Management, LP has disclosed MRNA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Encore Global Management, LP's current position in MRNA?

As of Q3 2026, Encore Global Management, LP holds 1.00K shares of MRNA (MODERNA INC), valued at $192.57K, representing 0.21% of its reported portfolio and ranking #45.

Has Encore Global Management, LP been buying or selling MRNA?

In the latest 13F filing (Q3 2026), Encore Global Management, LP held unchanged its position in MRNA. The position peaked in Q3 2026 at 1.00K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.